Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: A systematic review and meta-analysis.

Cancer Med · 2023 · PMC10757081 · PMID 38063264

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

When analyzing OS ( n = 2082) in Stage I‐III patients and Stage IV patients, the combined treatment effect of ICI and CT was marginally better but did not reach statistical significance ( p > 0.05) (Figure 7 ). 3.8.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.